This Frost & Sullivan report evaluates the potential of a full range of product segments in the interventional cardiovascular device industry from percutaneous transluminal coronary angioplasty balloon catheters to thrombectomy devices. It examines market drivers and restraints, presents revenue forecasts for each segment, analyzes the competitive structure of the marketplace, and highlights corporate trends. It also identifies new product advancements and the impact they will have on each market segment, and includes profiles of key industry participants.
